American Industrial Partners Completes Acquisition of Avanos Medical, Inc.

American Industrial Partners (AIP) has finalized its acquisition of Avanos Medical, Inc. in a transaction valued at approximately $1.272 billion. The deal, which closed on July 27, 2026, stipulates that Avanos stockholders will receive $25.00 in cash for each share of common stock they own. Following the completion of this transaction, Avanos' common stock will cease trading on the New York Stock Exchange, and the company will transition to a private entity.

Avanos Medical, headquartered in Alpharetta, Georgia, specializes in medical technology, focusing on delivering innovative device solutions that address critical healthcare needs. The company is recognized for its commitment to improving patient outcomes, particularly in areas such as nutrition and pain management. With a diverse portfolio of products, Avanos has established leading market positions across various categories, which positions it well for future growth.

The strategic rationale behind AIP's acquisition lies in its operational expertise and resources, which are expected to enhance Avanos' growth trajectory in the medical technology sector. AIP has a history of investing in engineered products businesses and aims to leverage its experience to implement transformative operational strategies at Avanos. This partnership is anticipated to accelerate Avanos' innovation roadmap and expand its capabilities in delivering clinically superior solutions to healthcare providers and patients.

The medical technology sector is currently experiencing significant growth, driven by advancements in technology and an increasing demand for innovative healthcare solutions. The acquisition of Avanos by AIP underscores the trend of private equity firms targeting companies with strong growth potential in this sector. As healthcare continues to evolve, the integration of operational efficiencies and innovative product development will be critical for companies looking to maintain competitive advantages.

In summary, the acquisition of Avanos Medical by American Industrial Partners represents a significant transaction in the medical technology landscape, with implications for both companies involved. As Avanos transitions to private ownership, it is poised to capitalize on its existing momentum and explore new opportunities for growth, supported by AIP's operational expertise. This deal reflects broader trends in the market, where private equity investment is increasingly focused on companies that can deliver innovative solutions in response to evolving healthcare challenges.